Dr. James Casey, MD (he/him) is a Pediatric Endocrinologist in Topeka, KS with over 18 years of experience. What is your opinion of Dr. James Casey, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 18 Years of Experience
Languages Spoken
English
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. James Casey, MD has received over $18,460 which includes payments from the following companies:
$12,246.30 from AbbVie, Inc.
$2,380.63 from Novo Nordisk AS
$2,153.91 from Merck Sharp & Dohme Corporation
$844.90 from Novo Nordisk Inc
$181.14 from Pfizer Inc.
$94.39 from Endo Pharmaceuticals Inc.
$71.29 from Sandoz Inc.
$61.91 from Janssen Pharmaceuticals, Inc
$55.19 from Tandem Diabetes Care, Inc.
$47.20 from Animas Corporation
$42.29 from sanofi-aventis U.S. LLC
$36.51 from INSULET CORPORATION
$35.22 from LILLY USA, LLC
$33.39 from Alexion Pharmaceuticals, Inc.
$32.28 from Aegerion Pharmaceuticals, Inc.
$26.08 from VIVUS, Inc.
$25.38 from Ferring Pharmaceuticals Inc.
$20.95 from Roche Diagnostics Corporation
$16.19 from GlaxoSmithKline, LLC.
$15.03 from E.R. Squibb & Sons, L.L.C.
Payments received by Dr. James Casey, MD were from the following categories:
$10,580.00 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!